Gilead And Teva Drug Buyers Lose Bid For New Antitrust Trial
By Hailey Konnath · November 1, 2023, 11:54 PM EDT
A California federal judge on Wednesday refused to grant HIV medication purchasers a new trial following a jury's verdict clearing Gilead and Teva in a $3.6 billion antitrust case claiming they...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login